NMPA Approval

Hydroxylcamptothecine Injection

Approval Number

国药准字H45021213

Company广西河丰药业有限责任公司

Registration Date

September 28, 2020

Previous Approval Numbers

国药准字H45021213

Drug Information

Generic Name

羟喜树碱注射液

Dosage Form

注射剂

Strength

5ml:5mg

Drug Type

化学药品

Registration Date

September 28, 2020

Company Information

Applicant Company

Company Name广西河丰药业有限责任公司

Company Address

广西东兰县第三开发区

Manufacturing Company

Company Name广西河丰药业有限责任公司

Company Address

广西东兰县第三开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

羟喜树碱注射液 - NMPA 批准文号 | MedPath